期刊文献+

SPECT/CT双探头符合线路衰减与非衰减校正在肿瘤诊断中的应用 被引量:3

Lesion-to-background ratio in tumor 18F-FDG SPECT-CT with or without attenuation
下载PDF
导出
摘要 目的 评价SPECT CT双探头符合线路衰减和非衰减校正技术对肿瘤诊断的意义。方法 用1 8F 脱氧葡萄糖 (FDG)SPECT双探头符合线路显像 ,经衰减和非衰减校正测量病灶的靶与本底 (L B)比值。结果 ①衰减校正检出恶性病变 4 1例 (5 6个病灶 )、良性病变 7例 (11个病灶 ) ;非衰减校正检出的良恶性病变部位和数量与衰减校正一致。②经衰减校正检出的 5 6个恶性病灶L B比值为 2 4 .0 7~ 1.39,平均 5 .2 0± 4 .2 8,其中 <2 .0为 8个 ,2 .0~ 2 .5为 7个 ,>2 .5为 4 1个 ;良性病灶 11个 ,L B比值为 2 0 .1~ 1.4 8,平均 5 .6 1± 4 .79,其中 <2 .0为 2个 ,2 .0~ 2 .5为 2个 ,>2 .5为 7个。③经衰减校正良恶性病灶L B比值平均为 5 .2 8± 3.5 1,非衰减校正为 3.2 2± 2 .0 0 ,两者间差异无显著性(P >0 .0 5 ) ,且呈正相关 (r =0 .77,P <0 .0 1)。结论 1 8F FDGSPECT双探头符合线路显像中衰减和非衰减校正对检出病灶数量和定位无明显区别 ,但前者图像明显好于后者。仅据L B比值判断良恶性病变不可靠。 ObjectiveTo compare the diagnostic efficacy of attenuation and non-attenuation in tumor 18F-FDG SPECT-CT. MethodsForty-eight cases underwent 18F-FDG SPECT-CT. Among them, 41 were with malignant tumors (56 lesions) and 7 were with benign space occupying lesions (11 lesions). Reconstructed attenuation-corrected and uncorrected images were displayed and the FDG uptake in lesions and corresponding background areas (L/B) were evaluated by the region of interest method. Results[WAlthough the numbers of lesions were not different between attenuated-corrected and uncorrected images, the attenuated images were clearer than uncorrected ones. The average ratio of L/B of attenuation group was 5.28±3.51, higher than the ratio of L/B of non-attenuation group, 3.22±2.00. There was a linear correlation between L/B ratios calculated on attenuated and non-attenuated images (r=0.77, P<0.01). ConclusionsAttenuation is worthwhile to use for the diagnosis of tumor. The ratio of L/B alone has its limitations to differentiate benignancy from malignancy.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2002年第6期333-334,共2页 Chinese Journal of Nuclear Medicine
关键词 诊断 肿瘤 脱氧葡萄糖 SPECT CT 衰减校正 Neoplasms Tomography, emission-computed, single-photon Deoxyglucose Tomography, X-ray computed Attenuation correction
  • 相关文献

参考文献6

  • 1Delbeke D, Sandler MP. The role of hybrid camera in oncology. Semin Nucl Med, 2000, 30:268-280.
  • 2Tatsumi M, Yutani K, Watanabe Y, et al. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer comparison with FDG PET. J Nucl Med, 1999,40:566-573.
  • 3Martin WH, Delbeke D, Patton JA, et al. Detection of malignancies with SPECT versus PET, with-2[18F]fluoro-2-deoxy-D-glucose.Radiology, 1996,198:225-231.
  • 4Lowe VJ, Duhaylongsod FG, Patz EF, et al. Pulmonary abnormalities and PET data analysis. A retrospective study. Radiology, 1997,202:435-439.
  • 5Shreve P, Steventon RS, Deters E, et al. FDG imaging of neoplasms using a dual head SPECT camera operated in coincidence mode (Abstract). Eur J Nucl Med, 1997, 24:860.
  • 6Imran MB, Kubota K, Yamada S, et al. Lesion-to-background ratio in nonattenuation-attenuation corrected whole-body FDG PET images. J Nucl Med, 1998,39:1219-1223.

同被引文献18

  • 1Kotzerk J, Guhlmann A, Moog F, et al. Role of attenuation correction for 18F-Fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma[J]. Eur J Nucl Med, 1999, 26: 31-38.
  • 2Zimny M, Kaiser HJ, Cremerius U, et al. Dual-head gamma camera 2-18F fluoro-2-deoxyglucose-D-glucose positron emission tomographay in oncological patients: effects of non-uniform attenuation correction on lesion detection[J]. Eur J Nucl Med, 1999,26: 818-
  • 3Kao CH, Shian YC, Shen YY, et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxylso- butylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglueose positron emission tomography[J]. Cancer , 2002;94(7) :1981-1986.
  • 4Patton JA, Delbeke D, Sandler MP. Imaging fusion using an integrated, dual-head coincidence camera with X-ray tubebased attenuation maps[J].J Nucl Med , 2000,41 (6) : 1364-1368.
  • 5Beyer T, Townsend DW,Brum T, et al . A combined PET/CT scanner for clinical oncology[J]. J Nucl Med , 2000,41(6) : 1369-1379.
  • 6Delbeke D,Delbeke D, Sandier MP. The role of hybrid camera in oncology[J]. Semin Nucl Med ,2002,30(4) :268-280.
  • 7Tatsumi M,Yutani K, Watanabe Y, et al . Feasibility of flurodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer,, comparison with FDG PET[J]. J Nucl Med ,1999,40:566-573.
  • 8Stokkel MP, ten Broek FW, Hodijk GJ, et al . preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography[J]. Ann Surg ,2000,231(2) :229-234.
  • 9Schillaci O,Danieli R,Manni C,et al.Technetium-99m-labelled red blood cell imaging in the diagnosis of hepatic haemangiomas:the role of SPECT/CT with a hybrid camera[J].Eur J Nucl Med Mol Imaging,2004,31(7):1011-1015.
  • 10Schillaci O,Simonetti G.Fusion imaging in nuclear medicine-applications of dual-modality systems in oncology[J].Cancer Biother Radiopharm,2004,19(1):1-10.

引证文献3

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部